Viewing Study NCT03149003


Ignite Creation Date: 2025-12-24 @ 7:37 PM
Ignite Modification Date: 2026-01-06 @ 3:56 AM
Study NCT ID: NCT03149003
Status: COMPLETED
Last Update Posted: 2023-11-15
First Post: 2017-05-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
Sponsor: Sumitomo Pharma America, Inc.
Organization: